Wafergen Biosystems said this week that it has reached an agreement with the Luxembourg government to locate its European headquarters in the country.

Wafergen said that the agreement would support the commercialization strategy for its SmartChip Real-Time PCR system, due to launch later this year.

The new Luxembourg location will house Wafergen's European marketing and sales, service and support, distribution, management of any subsidiaries and distributors, IP management, and some R&D activities, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.